Axogen gets FDA OK for Avance’s biologics license application

Dow Jones futures remained higher Thursday morning after another round of cool inflation data, with the release of the June{...}

Vistra Has Progress, But Not Enough For A Buy Source link{...}

Wow, talk about a splash in the markets! One stock is making waves today with a solid jump, tied to{...}